Aratana Therapeutics, Inc.. (PETX) NASDAQ

$4.92 0 (0.00%)

Market Cap: $0

As of 07/18/19 04:00 PM EDT. Market closed.

(PETX)

Aratana Therapeutics, Inc.. (PETX) NASDAQ

$4.92 0 (0.00%)

Market Cap: $0

As of 07/18/19 04:00 PM EDT. Market closed.

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ... read more

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO Compensation (Base)
$528,390
CEO Compensation (Total)
$2.09M
URL
Address
11400 Tomahawk Creek Parkway, KS, Leawood, 66211.
Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO Compensation (Base)
$528,390
CEO Compensation (Total)
$2.09M
Address
11400 Tomahawk Creek Parkway, KS, Leawood, 66211.
KEY STATS
Open
$0
Previous Close
$4.92
Days Range
$0 - $0
52 week range
$3.30 - $7.16
Volume
0
Avg. Volume (30 days)
850,576
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$4.92
Days Range
$0 - $0
52 week range
$3.30 - $7.16
Volume
0
Avg. Volume (30 days)
850,576
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARATANA THERAPEUTICS, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
AYRES JOHN C SEE REMARKS Jan 30, 2019 Sale $4.19 3,125 13,094 129,889 Feb 01, 2019, 05:45 PM
TOOMAN CRAIG A President, CEO and CFO Jan 24, 2019 Option Exercise $4.22 18,490 78,028 307,501 Jan 28, 2019, 05:50 PM
St Peter Steven PRESIDENT AND CEO Dec 17, 2018 Sale $5.85 46,094 269,788 516,626 Dec 17, 2018, 06:00 PM
HEINEN ERNST Chief Development Officer Nov 07, 2018 Sale $6.95 19,308 134,191 135,694 Nov 09, 2018, 06:00 PM
HEINEN ERNST Chief Development Officer Nov 02, 2018 Sale $6.95 692 4,809 155,002 Nov 06, 2018, 06:05 PM
St Peter Steven PRESIDENT AND CEO Oct 30, 2018 Sale $5.86 11,513 67,454 562,720 Oct 31, 2018, 06:00 PM
St Peter Steven PRESIDENT AND CEO Sep 21, 2018 Sale $6.06 75,000 454,305 574,233 Sep 21, 2018, 06:31 PM
HEINEN ERNST Chief Development Officer Aug 13, 2018 Sale $5.15 8,660 44,599 157,406 Aug 14, 2018, 05:32 PM
HEINEN ERNST Chief Development Officer Aug 14, 2018 Sale $5.15 1,712 8,817 155,694 Aug 14, 2018, 05:32 PM
HEINEN ERNST Chief Development Officer Aug 10, 2018 Sale $5.15 1,954 10,063 166,066 Aug 10, 2018, 05:45 PM
HEINEN ERNST Chief Development Officer Aug 08, 2018 Sale $5.15 2,674 13,771 168,020 Aug 10, 2018, 05:45 PM
St Peter Steven PRESIDENT AND CEO Jul 30, 2018 Sale $4.33 11,513 49,842 649,233 Jul 30, 2018, 05:51 PM
Standridge Brent Chief Operating Officer Jun 25, 2018 Sale $4.56 10,000 45,644 99,967 Jun 27, 2018, 05:32 PM
St Peter Steven PRESIDENT AND CEO Apr 30, 2018 Sale $5.00 11,513 57,582 660,746 May 01, 2018, 08:00 PM
St Peter Steven PRESIDENT AND CEO Apr 30, 2018 Sale $5.00 11,513 57,582 660,746 Apr 30, 2018, 05:49 PM
St Peter Steven PRESIDENT AND CEO Jan 30, 2018 Sale $4.77 19,367 92,301 672,259 Feb 01, 2018, 05:29 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Jan 11, 2018 Sale $5.27 30,000 158,040 75,024 Jan 12, 2018, 05:37 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Dec 21, 2017 Option Exercise $3.14 2,000 6,280 105,024 Dec 21, 2017, 06:09 PM
St Peter Steven PRESIDENT AND CEO Dec 20, 2017 Option Exercise $3.14 26,667 83,734 556,026 Dec 21, 2017, 06:06 PM
Broadfin Healthcare Master Fund Ltd 10% Owner Nov 30, 2017 Sale $5.94 211,572 1,256,591 5,068,326 Dec 01, 2017, 05:01 PM
Broadfin Healthcare Master Fund Ltd 10% Owner Nov 29, 2017 Sale $6.53 116,516 761,111 5,183,942 Dec 01, 2017, 05:01 PM
Broadfin Healthcare Master Fund Ltd 10% Owner Dec 01, 2017 Sale $5.44 562,428 3,059,350 4,784,854 Dec 01, 2017, 05:01 PM
St Peter Steven PRESIDENT AND CEO Nov 10, 2017 Sale $7.00 50,000 350,000 529,359 Nov 13, 2017, 06:05 PM
St Peter Steven PRESIDENT AND CEO Oct 02, 2017 Sale $6.24 50,000 312,115 579,359 Oct 04, 2017, 06:00 PM
Standridge Brent Chief Operating Officer Sep 25, 2017 Sale $6.11 10,000 61,127 70,267 Sep 27, 2017, 06:00 PM
HEINEN ERNST Chief Development Officer Sep 15, 2017 Sale $6.25 10,000 62,500 130,994 Sep 19, 2017, 06:03 PM
Broadfin Healthcare Master Fund Ltd 10% Owner May 19, 2017 Option Exercise $7.50 729,500 5,471,250 5,184,942 May 22, 2017, 01:51 PM
St Peter Steven PRESIDENT AND CEO Apr 17, 2017 Option Exercise $3.14 46,666 146,531 629,359 Apr 18, 2017, 06:06 PM
St Peter Steven PRESIDENT AND CEO Apr 17, 2017 Sale $5.54 50,000 277,150 582,693 Apr 18, 2017, 06:06 PM
St Peter Steven PRESIDENT AND CEO Jan 27, 2017 Sale $7.72 50,000 385,875 632,693 Jan 31, 2017, 06:03 PM
St Peter Steven PRESIDENT AND CEO Dec 15, 2016 Sale $7.63 50,000 381,380 542,793 Dec 16, 2016, 05:49 PM
HEINEN ERNST Chief Development Officer Oct 03, 2016 Sale $10.00 10,000 100,006 115,494 Oct 04, 2016, 06:01 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Sep 09, 2016 Sale $9.25 30,000 277,599 72,424 Sep 12, 2016, 06:04 PM
St Peter Steven PRESIDENT AND CEO Aug 09, 2016 Sale $9.25 50,000 462,500 642,793 Aug 10, 2016, 06:19 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jun 28, 2016 Sale $6.25 30,000 187,500 127,503 Jun 28, 2016, 06:25 PM
HEINEN ERNST Chief Development Officer Jun 10, 2016 Sale $6.72 15,000 100,862 125,494 Jun 13, 2016, 06:32 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Feb 01, 2016 Sale $3.36 2,806 9,436 102,424 Feb 02, 2016, 07:16 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Nov 09, 2015 Sale $7.52 3,620 27,238 69,980 Nov 10, 2015, 06:09 PM
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER Oct 02, 2015 Sale $8.06 3,250 26,188 73,600 Oct 02, 2015, 07:34 PM
HEINEN ERNST Chief Development Officer Jul 15, 2015 Sale $17.06 15,000 255,831 97,494 Jul 17, 2015, 05:36 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Apr 27, 2015 Sale $15.00 15,000 224,985 426,505 Apr 28, 2015, 06:09 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Mar 06, 2015 Sale $20.00 20,000 400,000 421,005 Mar 06, 2015, 06:34 PM
Vander Vort John Director Mar 06, 2015 Sale $20.01 6,137 122,776 25,000 Mar 06, 2015, 06:31 PM
St Peter Steven PRESIDENT AND CEO Jan 13, 2015 Sale $19.23 75,000 1,442,407 609,394 Jan 13, 2015, 06:04 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jan 13, 2015 Sale $19.00 6,300 119,700 112,803 Jan 13, 2015, 06:02 PM
St Peter Steven PRESIDENT AND CEO Jan 02, 2015 Sale $17.87 25,000 446,648 684,394 Jan 06, 2015, 05:05 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Dec 22, 2014 Sale $18.00 10,000 180,000 441,005 Dec 23, 2014, 05:06 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Oct 06, 2014 Option Exercise $6.00 4,700 28,200 451,005 Oct 08, 2014, 05:37 PM
St Peter Steven PRESIDENT AND CEO Sep 03, 2014 Option Exercise $6.00 25,000 150,000 734,394 Sep 04, 2014, 06:06 PM
St Peter Steven PRESIDENT AND CEO Sep 02, 2014 Sale $11.67 25,000 291,863 709,394 Sep 04, 2014, 06:06 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Aug 25, 2014 Option Exercise $12.16 288 3,502 119,103 Aug 26, 2014, 06:27 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jul 25, 2014 Option Exercise $12.45 288 3,586 119,391 Jul 28, 2014, 05:05 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jul 03, 2014 Sale $17.33 2,000 34,660 119,679 Jul 03, 2014, 04:57 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Jul 01, 2014 Sale $16.00 10,000 160,000 446,305 Jul 03, 2014, 04:54 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jun 25, 2014 Option Exercise $14.79 288 4,260 121,679 Jun 26, 2014, 05:04 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Jun 17, 2014 Sale $15.00 4,626 69,390 456,305 Jun 17, 2014, 06:05 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jun 16, 2014 Sale $13.90 8,000 111,164 121,967 Jun 16, 2014, 06:49 PM
Rhodes Linda CHIEF SCIENTIFIC OFFICER Jun 09, 2014 Sale $15.00 5,374 80,610 460,931 Jun 11, 2014, 06:10 PM
St Peter Steven PRESIDENT AND CEO Jun 02, 2014 Sale $13.47 25,000 336,805 734,394 Jun 02, 2014, 06:55 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER May 25, 2014 Option Exercise $12.57 288 3,620 129,967 May 27, 2014, 05:41 PM
HEINEN ERNST Chief Development Officer May 05, 2014 Sale $13.42 10,000 134,200 95,294 May 05, 2014, 05:11 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Apr 25, 2014 Option Exercise $13.55 288 3,902 130,255 Apr 28, 2014, 05:25 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Mar 26, 2014 Option Exercise $19.00 4,009 76,159 131,119 Mar 28, 2014, 05:12 PM
MPM BIOVENTURES V, L.P. 10% Owner Mar 10, 2014 Sale $20.02 600,000 12,012,000 2,751,048 Mar 12, 2014, 06:55 PM
GADICKE ANSBERT 10% Owner Mar 07, 2014 Sale $20.16 26,713 538,534 0 Mar 11, 2014, 04:48 PM
Foley Todd 10% Owner Mar 07, 2014 Sale $19.95 12,539 250,153 0 Mar 11, 2014, 04:47 PM
Lichter Jay Director Feb 03, 2014 Sale $19.00 825,000 15,675,000 3,345,543 Feb 05, 2014, 04:29 PM
Avalon Ventures IX, L.P. 10% Owner Feb 03, 2014 Sale $19.00 825,000 15,675,000 3,345,543 Feb 05, 2014, 04:25 PM
MEEUSEN RONALD L Director Feb 03, 2014 Sale $19.00 500,000 9,500,000 759,857 Feb 05, 2014, 02:14 PM
Lichter Jay Director Jul 02, 2013 Buy $6.00 500,000 3,000,000 4,170,543 Feb 04, 2014, 04:54 PM
Avalon Ventures IX, L.P. 10% Owner Jul 02, 2013 Buy $6.00 500,000 3,000,000 4,170,545 Jul 08, 2013, 07:04 PM
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER Jul 02, 2013 Buy $6.00 2,000 12,000 134,552 Jul 03, 2013, 06:06 PM
St Peter Steven PRESIDENT AND CEO Jul 02, 2013 Buy $6.00 8,333 49,998 529,191 Jul 03, 2013, 06:04 PM
Vander Vort John Director Jul 02, 2013 Buy $6.00 500,000 3,000,000 4,351,050 Jul 02, 2013, 05:08 PM
MPM BIOVENTURES V, L.P. 10% Owner Jul 02, 2013 Buy $6.00 500,000 3,000,000 4,351,050 Jul 02, 2013, 05:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
AYRES JOHN C SEE REMARKS 01/30/2019 13,094
TOOMAN CRAIG A President, CEO and CFO 01/24/2019 78,028
St Peter Steven PRESIDENT AND CEO 12/17/2018 269,788
HEINEN ERNST Chief Development Officer 11/07/2018 134,191
HEINEN ERNST Chief Development Officer 11/02/2018 4,809
St Peter Steven PRESIDENT AND CEO 10/30/2018 67,454
St Peter Steven PRESIDENT AND CEO 09/21/2018 454,305
HEINEN ERNST Chief Development Officer 08/13/2018 44,599
HEINEN ERNST Chief Development Officer 08/14/2018 8,817
HEINEN ERNST Chief Development Officer 08/10/2018 10,063
HEINEN ERNST Chief Development Officer 08/08/2018 13,771
St Peter Steven PRESIDENT AND CEO 07/30/2018 49,842
Standridge Brent Chief Operating Officer 06/25/2018 45,644
St Peter Steven PRESIDENT AND CEO 04/30/2018 57,582
St Peter Steven PRESIDENT AND CEO 04/30/2018 57,582
St Peter Steven PRESIDENT AND CEO 01/30/2018 92,301
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 01/11/2018 158,040
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 12/21/2017 6,280
St Peter Steven PRESIDENT AND CEO 12/20/2017 83,734
Broadfin Healthcare Master Fund Ltd 10% Owner 11/30/2017 1,256,591
Broadfin Healthcare Master Fund Ltd 10% Owner 11/29/2017 761,111
Broadfin Healthcare Master Fund Ltd 10% Owner 12/01/2017 3,059,350
St Peter Steven PRESIDENT AND CEO 11/10/2017 350,000
St Peter Steven PRESIDENT AND CEO 10/02/2017 312,115
Standridge Brent Chief Operating Officer 09/25/2017 61,127
HEINEN ERNST Chief Development Officer 09/15/2017 62,500
Broadfin Healthcare Master Fund Ltd 10% Owner 05/19/2017 5,471,250
St Peter Steven PRESIDENT AND CEO 04/17/2017 146,531
St Peter Steven PRESIDENT AND CEO 04/17/2017 277,150
St Peter Steven PRESIDENT AND CEO 01/27/2017 385,875
St Peter Steven PRESIDENT AND CEO 12/15/2016 381,380
HEINEN ERNST Chief Development Officer 10/03/2016 100,006
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 09/09/2016 277,599
St Peter Steven PRESIDENT AND CEO 08/09/2016 462,500
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 06/28/2016 187,500
HEINEN ERNST Chief Development Officer 06/10/2016 100,862
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 02/01/2016 9,436
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 11/09/2015 27,238
TOOMAN CRAIG A CHIEF FINANCIAL OFFICER 10/02/2015 26,188
HEINEN ERNST Chief Development Officer 07/15/2015 255,831
Rhodes Linda CHIEF SCIENTIFIC OFFICER 04/27/2015 224,985
Rhodes Linda CHIEF SCIENTIFIC OFFICER 03/06/2015 400,000
Vander Vort John Director 03/06/2015 122,776
St Peter Steven PRESIDENT AND CEO 01/13/2015 1,442,407
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 01/13/2015 119,700
St Peter Steven PRESIDENT AND CEO 01/02/2015 446,648
Rhodes Linda CHIEF SCIENTIFIC OFFICER 12/22/2014 180,000
Rhodes Linda CHIEF SCIENTIFIC OFFICER 10/06/2014 28,200
St Peter Steven PRESIDENT AND CEO 09/03/2014 150,000
St Peter Steven PRESIDENT AND CEO 09/02/2014 291,863
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 08/25/2014 3,502
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 07/25/2014 3,586
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 07/03/2014 34,660
Rhodes Linda CHIEF SCIENTIFIC OFFICER 07/01/2014 160,000
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 06/25/2014 4,260
Rhodes Linda CHIEF SCIENTIFIC OFFICER 06/17/2014 69,390
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 06/16/2014 111,164
Rhodes Linda CHIEF SCIENTIFIC OFFICER 06/09/2014 80,610
St Peter Steven PRESIDENT AND CEO 06/02/2014 336,805
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 05/25/2014 3,620
HEINEN ERNST Chief Development Officer 05/05/2014 134,200
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 04/25/2014 3,902
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 03/26/2014 76,159
MPM BIOVENTURES V, L.P. 10% Owner 03/10/2014 12,012,000
GADICKE ANSBERT 10% Owner 03/07/2014 538,534
Foley Todd 10% Owner 03/07/2014 250,153
Lichter Jay Director 02/03/2014 15,675,000
Avalon Ventures IX, L.P. 10% Owner 02/03/2014 15,675,000
MEEUSEN RONALD L Director 02/03/2014 9,500,000
Lichter Jay Director 07/02/2013 3,000,000
Avalon Ventures IX, L.P. 10% Owner 07/02/2013 3,000,000
STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER 07/02/2013 12,000
St Peter Steven PRESIDENT AND CEO 07/02/2013 49,998
Vander Vort John Director 07/02/2013 3,000,000
MPM BIOVENTURES V, L.P. 10% Owner 07/02/2013 3,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2019
12/31/2018
3.58%
1Q
03/31/2019
09/30/2018
4.66%
2Q
03/31/2019
06/30/2018
6.04%
3Q
03/31/2019
03/31/2018
7.79%
4Q
03/31/2019
09/30/2017
21.24%
6Q
03/31/2019
06/30/2017
25.44%
7Q
03/31/2019
12/31/2016
36.87%
9Q
03/31/2019
09/30/2016
38.58%
10Q
03/31/2019
06/30/2016
38.81%
11Q
03/31/2019
03/31/2016
39.31%
12Q
03/31/2019
12/31/2015
40.52%
13Q
Load More

Period of Report: 03/31/2019

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2018
3.58%
1Q
09/30/2018
4.66%
2Q
06/30/2018
6.04%
3Q
03/31/2018
7.79%
4Q
09/30/2017
21.24%
6Q
06/30/2017
25.44%
7Q
12/31/2016
36.87%
9Q
09/30/2016
38.58%
10Q
06/30/2016
38.81%
11Q
03/31/2016
39.31%
12Q
12/31/2015
40.52%
13Q
Load More